 | • レポートコード：MRC2-11QY02567 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗マラリア薬のグローバル市場について調査・分析したレポートです。種類別（熱帯熱マラリア原虫、マラリア原虫、ビバックスマラリア原虫、卵形マラリア原虫）市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗マラリア薬の競争状況、市場シェア ・世界の抗マラリア薬市場：種類別市場規模 2015年-2020年（熱帯熱マラリア原虫、マラリア原虫、ビバックスマラリア原虫、卵形マラリア原虫） ・世界の抗マラリア薬市場：種類別市場規模予測 2021年-2026年（熱帯熱マラリア原虫、マラリア原虫、ビバックスマラリア原虫、卵形マラリア原虫） ・世界の抗マラリア薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、Eコマース、その他） ・世界の抗マラリア薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、Eコマース、その他） ・北米の抗マラリア薬市場分析：米国、カナダ ・ヨーロッパの抗マラリア薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗マラリア薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗マラリア薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗マラリア薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、F. Hoffmann-La Roche、Novartis、Pfizer、Sun Pharmaceutical Industries、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.
Antimalarial medication are the medicines used to prevent and treat malaria.
Market Analysis and Insights: Global Antimalarial Medication Market
The global Antimalarial Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Antimalarial Medication Scope and Market Size
Antimalarial Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antimalarial Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antimalarial Medication market is segmented into
Plasmodium Falciparum
Plasmodium Malariae
Plasmodium Vivax
Plasmodium Ovale
Segment by Application, the Antimalarial Medication market is segmented into
Hospital Pharmacy
Retail Pharmacy
E- Commerce
Others
Regional and Country-level Analysis
The Antimalarial Medication market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antimalarial Medication market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antimalarial Medication Market Share Analysis
Antimalarial Medication market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antimalarial Medication business, the date to enter into the Antimalarial Medication market, Antimalarial Medication product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
F. Hoffmann-La Roche
Novartis
Pfizer
Sun Pharmaceutical Industries
Merck
…
1 Study Coverage
1.1 Antimalarial Medication Product Introduction
1.2 Market Segments
1.3 Key Antimalarial Medication Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antimalarial Medication Market Size Growth Rate by Type
1.4.2 Plasmodium Falciparum
1.4.3 Plasmodium Malariae
1.4.4 Plasmodium Vivax
1.4.5 Plasmodium Ovale
1.5 Market by Application
1.5.1 Global Antimalarial Medication Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 E- Commerce
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antimalarial Medication Market Size, Estimates and Forecasts
2.1.1 Global Antimalarial Medication Revenue 2015-2026
2.1.2 Global Antimalarial Medication Sales 2015-2026
2.2 Global Antimalarial Medication, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antimalarial Medication Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antimalarial Medication Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antimalarial Medication Competitor Landscape by Players
3.1 Antimalarial Medication Sales by Manufacturers
3.1.1 Antimalarial Medication Sales by Manufacturers (2015-2020)
3.1.2 Antimalarial Medication Sales Market Share by Manufacturers (2015-2020)
3.2 Antimalarial Medication Revenue by Manufacturers
3.2.1 Antimalarial Medication Revenue by Manufacturers (2015-2020)
3.2.2 Antimalarial Medication Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antimalarial Medication Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antimalarial Medication Revenue in 2019
3.2.5 Global Antimalarial Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antimalarial Medication Price by Manufacturers
3.4 Antimalarial Medication Manufacturing Base Distribution, Product Types
3.4.1 Antimalarial Medication Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antimalarial Medication Product Type
3.4.3 Date of International Manufacturers Enter into Antimalarial Medication Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antimalarial Medication Market Size by Type (2015-2020)
4.1.1 Global Antimalarial Medication Sales by Type (2015-2020)
4.1.2 Global Antimalarial Medication Revenue by Type (2015-2020)
4.1.3 Antimalarial Medication Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antimalarial Medication Market Size Forecast by Type (2021-2026)
4.2.1 Global Antimalarial Medication Sales Forecast by Type (2021-2026)
4.2.2 Global Antimalarial Medication Revenue Forecast by Type (2021-2026)
4.2.3 Antimalarial Medication Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antimalarial Medication Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antimalarial Medication Market Size by Application (2015-2020)
5.1.1 Global Antimalarial Medication Sales by Application (2015-2020)
5.1.2 Global Antimalarial Medication Revenue by Application (2015-2020)
5.1.3 Antimalarial Medication Price by Application (2015-2020)
5.2 Antimalarial Medication Market Size Forecast by Application (2021-2026)
5.2.1 Global Antimalarial Medication Sales Forecast by Application (2021-2026)
5.2.2 Global Antimalarial Medication Revenue Forecast by Application (2021-2026)
5.2.3 Global Antimalarial Medication Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antimalarial Medication by Country
6.1.1 North America Antimalarial Medication Sales by Country
6.1.2 North America Antimalarial Medication Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antimalarial Medication Market Facts & Figures by Type
6.3 North America Antimalarial Medication Market Facts & Figures by Application
7 Europe
7.1 Europe Antimalarial Medication by Country
7.1.1 Europe Antimalarial Medication Sales by Country
7.1.2 Europe Antimalarial Medication Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antimalarial Medication Market Facts & Figures by Type
7.3 Europe Antimalarial Medication Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antimalarial Medication by Region
8.1.1 Asia Pacific Antimalarial Medication Sales by Region
8.1.2 Asia Pacific Antimalarial Medication Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antimalarial Medication Market Facts & Figures by Type
8.3 Asia Pacific Antimalarial Medication Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antimalarial Medication by Country
9.1.1 Latin America Antimalarial Medication Sales by Country
9.1.2 Latin America Antimalarial Medication Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antimalarial Medication Market Facts & Figures by Type
9.3 Central & South America Antimalarial Medication Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antimalarial Medication by Country
10.1.1 Middle East and Africa Antimalarial Medication Sales by Country
10.1.2 Middle East and Africa Antimalarial Medication Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antimalarial Medication Market Facts & Figures by Type
10.3 Middle East and Africa Antimalarial Medication Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Antimalarial Medication Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Corporation Information
11.2.2 F. Hoffmann-La Roche Description and Business Overview
11.2.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 F. Hoffmann-La Roche Antimalarial Medication Products Offered
11.2.5 F. Hoffmann-La Roche Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Antimalarial Medication Products Offered
11.3.5 Novartis Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Antimalarial Medication Products Offered
11.4.5 Pfizer Related Developments
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Corporation Information
11.5.2 Sun Pharmaceutical Industries Description and Business Overview
11.5.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sun Pharmaceutical Industries Antimalarial Medication Products Offered
11.5.5 Sun Pharmaceutical Industries Related Developments
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Description and Business Overview
11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Antimalarial Medication Products Offered
11.6.5 Merck Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Antimalarial Medication Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antimalarial Medication Market Estimates and Projections by Region
12.1.1 Global Antimalarial Medication Sales Forecast by Regions 2021-2026
12.1.2 Global Antimalarial Medication Revenue Forecast by Regions 2021-2026
12.2 North America Antimalarial Medication Market Size Forecast (2021-2026)
12.2.1 North America: Antimalarial Medication Sales Forecast (2021-2026)
12.2.2 North America: Antimalarial Medication Revenue Forecast (2021-2026)
12.2.3 North America: Antimalarial Medication Market Size Forecast by Country (2021-2026)
12.3 Europe Antimalarial Medication Market Size Forecast (2021-2026)
12.3.1 Europe: Antimalarial Medication Sales Forecast (2021-2026)
12.3.2 Europe: Antimalarial Medication Revenue Forecast (2021-2026)
12.3.3 Europe: Antimalarial Medication Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antimalarial Medication Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antimalarial Medication Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antimalarial Medication Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antimalarial Medication Market Size Forecast by Region (2021-2026)
12.5 Latin America Antimalarial Medication Market Size Forecast (2021-2026)
12.5.1 Latin America: Antimalarial Medication Sales Forecast (2021-2026)
12.5.2 Latin America: Antimalarial Medication Revenue Forecast (2021-2026)
12.5.3 Latin America: Antimalarial Medication Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antimalarial Medication Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antimalarial Medication Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antimalarial Medication Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antimalarial Medication Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antimalarial Medication Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antimalarial Medication Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antimalarial Medication Market Segments
Table 2. Ranking of Global Top Antimalarial Medication Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antimalarial Medication Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Plasmodium Falciparum
Table 5. Major Manufacturers of Plasmodium Malariae
Table 6. Major Manufacturers of Plasmodium Vivax
Table 7. Major Manufacturers of Plasmodium Ovale
Table 8. Global Antimalarial Medication Market Size Growth Rate by Application 2020-2026 (MT)
Table 9. Global Antimalarial Medication Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 10. Global Antimalarial Medication Sales by Regions 2015-2020 (MT)
Table 11. Global Antimalarial Medication Sales Market Share by Regions (2015-2020)
Table 12. Global Antimalarial Medication Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Antimalarial Medication Sales by Manufacturers (2015-2020) (MT)
Table 14. Global Antimalarial Medication Sales Share by Manufacturers (2015-2020)
Table 15. Global Antimalarial Medication Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Antimalarial Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antimalarial Medication as of 2019)
Table 17. Antimalarial Medication Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Antimalarial Medication Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Antimalarial Medication Price (2015-2020) (USD/Kg)
Table 20. Antimalarial Medication Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Antimalarial Medication Product Type
Table 22. Date of International Manufacturers Enter into Antimalarial Medication Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Antimalarial Medication Sales by Type (2015-2020) (MT)
Table 25. Global Antimalarial Medication Sales Share by Type (2015-2020)
Table 26. Global Antimalarial Medication Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Antimalarial Medication Revenue Share by Type (2015-2020)
Table 28. Antimalarial Medication Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 29. Global Antimalarial Medication Sales by Application (2015-2020) (MT)
Table 30. Global Antimalarial Medication Sales Share by Application (2015-2020)
Table 31. North America Antimalarial Medication Sales by Country (2015-2020) (MT)
Table 32. North America Antimalarial Medication Sales Market Share by Country (2015-2020)
Table 33. North America Antimalarial Medication Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Antimalarial Medication Revenue Market Share by Country (2015-2020)
Table 35. North America Antimalarial Medication Sales by Type (2015-2020) (MT)
Table 36. North America Antimalarial Medication Sales Market Share by Type (2015-2020)
Table 37. North America Antimalarial Medication Sales by Application (2015-2020) (MT)
Table 38. North America Antimalarial Medication Sales Market Share by Application (2015-2020)
Table 39. Europe Antimalarial Medication Sales by Country (2015-2020) (MT)
Table 40. Europe Antimalarial Medication Sales Market Share by Country (2015-2020)
Table 41. Europe Antimalarial Medication Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Antimalarial Medication Revenue Market Share by Country (2015-2020)
Table 43. Europe Antimalarial Medication Sales by Type (2015-2020) (MT)
Table 44. Europe Antimalarial Medication Sales Market Share by Type (2015-2020)
Table 45. Europe Antimalarial Medication Sales by Application (2015-2020) (MT)
Table 46. Europe Antimalarial Medication Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Antimalarial Medication Sales by Region (2015-2020) (MT)
Table 48. Asia Pacific Antimalarial Medication Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Antimalarial Medication Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Antimalarial Medication Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Antimalarial Medication Sales by Type (2015-2020) (MT)
Table 52. Asia Pacific Antimalarial Medication Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Antimalarial Medication Sales by Application (2015-2020) (MT)
Table 54. Asia Pacific Antimalarial Medication Sales Market Share by Application (2015-2020)
Table 55. Latin America Antimalarial Medication Sales by Country (2015-2020) (MT)
Table 56. Latin America Antimalarial Medication Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Antimalarial Medication Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Antimalarial Medication Revenue Market Share by Country (2015-2020)
Table 59. Latin America Antimalarial Medication Sales by Type (2015-2020) (MT)
Table 60. Latin America Antimalarial Medication Sales Market Share by Type (2015-2020)
Table 61. Latin America Antimalarial Medication Sales by Application (2015-2020) (MT)
Table 62. Latin America Antimalarial Medication Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Antimalarial Medication Sales by Country (2015-2020) (MT)
Table 64. Middle East and Africa Antimalarial Medication Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Antimalarial Medication Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Antimalarial Medication Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Antimalarial Medication Sales by Type (2015-2020) (MT)
Table 68. Middle East and Africa Antimalarial Medication Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Antimalarial Medication Sales by Application (2015-2020) (MT)
Table 70. Middle East and Africa Antimalarial Medication Sales Market Share by Application (2015-2020)
Table 71. GlaxoSmithKline Corporation Information
Table 72. GlaxoSmithKline Description and Major Businesses
Table 73. GlaxoSmithKline Antimalarial Medication Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 74. GlaxoSmithKline Product
Table 75. GlaxoSmithKline Recent Development
Table 76. F. Hoffmann-La Roche Corporation Information
Table 77. F. Hoffmann-La Roche Description and Major Businesses
Table 78. F. Hoffmann-La Roche Antimalarial Medication Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. F. Hoffmann-La Roche Product
Table 80. F. Hoffmann-La Roche Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Major Businesses
Table 83. Novartis Antimalarial Medication Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. Pfizer Corporation Information
Table 87. Pfizer Description and Major Businesses
Table 88. Pfizer Antimalarial Medication Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. Pfizer Product
Table 90. Pfizer Recent Development
Table 91. Sun Pharmaceutical Industries Corporation Information
Table 92. Sun Pharmaceutical Industries Description and Major Businesses
Table 93. Sun Pharmaceutical Industries Antimalarial Medication Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. Sun Pharmaceutical Industries Product
Table 95. Sun Pharmaceutical Industries Recent Development
Table 96. Merck Corporation Information
Table 97. Merck Description and Major Businesses
Table 98. Merck Antimalarial Medication Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. Merck Product
Table 100. Merck Recent Development
Table 101. Global Antimalarial Medication Sales Forecast by Regions (2021-2026) (MT)
Table 102. Global Antimalarial Medication Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Antimalarial Medication Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Antimalarial Medication Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Antimalarial Medication Sales Forecast by Country (2021-2026) (MT)
Table 106. North America: Antimalarial Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Antimalarial Medication Sales Forecast by Country (2021-2026) (MT)
Table 108. Europe: Antimalarial Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Antimalarial Medication Sales Forecast by Region (2021-2026) (MT)
Table 110. Asia Pacific: Antimalarial Medication Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Antimalarial Medication Sales Forecast by Country (2021-2026) (MT)
Table 112. Latin America: Antimalarial Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Antimalarial Medication Sales Forecast by Country (2021-2026) (MT)
Table 114. Middle East and Africa: Antimalarial Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Antimalarial Medication Players
Table 119. Antimalarial Medication Customers List
Table 120. Antimalarial Medication Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Antimalarial Medication Product Picture
Figure 2. Global Antimalarial Medication Sales Market Share by Type in 2020 & 2026
Figure 3. Plasmodium Falciparum Product Picture
Figure 4. Plasmodium Malariae Product Picture
Figure 5. Plasmodium Vivax Product Picture
Figure 6. Plasmodium Ovale Product Picture
Figure 7. Global Antimalarial Medication Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. E- Commerce
Figure 11. Others
Figure 12. Antimalarial Medication Report Years Considered
Figure 13. Global Antimalarial Medication Market Size 2015-2026 (US$ Million)
Figure 14. Global Antimalarial Medication Sales 2015-2026 (MT)
Figure 15. Global Antimalarial Medication Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Antimalarial Medication Sales Market Share by Region (2015-2020)
Figure 17. Global Antimalarial Medication Sales Market Share by Region in 2019
Figure 18. Global Antimalarial Medication Revenue Market Share by Region (2015-2020)
Figure 19. Global Antimalarial Medication Revenue Market Share by Region in 2019
Figure 20. Global Antimalarial Medication Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Antimalarial Medication Revenue in 2019
Figure 22. Antimalarial Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Antimalarial Medication Sales Market Share by Type (2015-2020)
Figure 24. Global Antimalarial Medication Sales Market Share by Type in 2019
Figure 25. Global Antimalarial Medication Revenue Market Share by Type (2015-2020)
Figure 26. Global Antimalarial Medication Revenue Market Share by Type in 2019
Figure 27. Global Antimalarial Medication Market Share by Price Range (2015-2020)
Figure 28. Global Antimalarial Medication Sales Market Share by Application (2015-2020)
Figure 29. Global Antimalarial Medication Sales Market Share by Application in 2019
Figure 30. Global Antimalarial Medication Revenue Market Share by Application (2015-2020)
Figure 31. Global Antimalarial Medication Revenue Market Share by Application in 2019
Figure 32. North America Antimalarial Medication Sales Growth Rate 2015-2020 (MT)
Figure 33. North America Antimalarial Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Antimalarial Medication Sales Market Share by Country in 2019
Figure 35. North America Antimalarial Medication Revenue Market Share by Country in 2019
Figure 36. U.S. Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 37. U.S. Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 39. Canada Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Antimalarial Medication Market Share by Type in 2019
Figure 41. North America Antimalarial Medication Market Share by Application in 2019
Figure 42. Europe Antimalarial Medication Sales Growth Rate 2015-2020 (MT)
Figure 43. Europe Antimalarial Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Antimalarial Medication Sales Market Share by Country in 2019
Figure 45. Europe Antimalarial Medication Revenue Market Share by Country in 2019
Figure 46. Germany Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 47. Germany Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 49. France Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 51. U.K. Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 53. Italy Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 55. Russia Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Antimalarial Medication Market Share by Type in 2019
Figure 57. Europe Antimalarial Medication Market Share by Application in 2019
Figure 58. Asia Pacific Antimalarial Medication Sales Growth Rate 2015-2020 (MT)
Figure 59. Asia Pacific Antimalarial Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Antimalarial Medication Sales Market Share by Region in 2019
Figure 61. Asia Pacific Antimalarial Medication Revenue Market Share by Region in 2019
Figure 62. China Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 63. China Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 65. Japan Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 67. South Korea Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 69. India Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 71. Australia Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 73. Taiwan Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 75. Indonesia Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 77. Thailand Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 79. Malaysia Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 81. Philippines Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 83. Vietnam Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Antimalarial Medication Market Share by Type in 2019
Figure 85. Asia Pacific Antimalarial Medication Market Share by Application in 2019
Figure 86. Latin America Antimalarial Medication Sales Growth Rate 2015-2020 (MT)
Figure 87. Latin America Antimalarial Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Antimalarial Medication Sales Market Share by Country in 2019
Figure 89. Latin America Antimalarial Medication Revenue Market Share by Country in 2019
Figure 90. Mexico Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 91. Mexico Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 93. Brazil Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 95. Argentina Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Antimalarial Medication Market Share by Type in 2019
Figure 97. Latin America Antimalarial Medication Market Share by Application in 2019
Figure 98. Middle East and Africa Antimalarial Medication Sales Growth Rate 2015-2020 (MT)
Figure 99. Middle East and Africa Antimalarial Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Antimalarial Medication Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Antimalarial Medication Revenue Market Share by Country in 2019
Figure 102. Turkey Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 103. Turkey Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 105. Saudi Arabia Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Antimalarial Medication Sales Growth Rate (2015-2020) (MT)
Figure 107. U.A.E Antimalarial Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Antimalarial Medication Market Share by Type in 2019
Figure 109. Middle East and Africa Antimalarial Medication Market Share by Application in 2019
Figure 110. North America Antimalarial Medication Sales Growth Rate Forecast (2021-2026) (MT)
Figure 111. North America Antimalarial Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Antimalarial Medication Sales Growth Rate Forecast (2021-2026) (MT)
Figure 113. Europe Antimalarial Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Antimalarial Medication Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. Asia Pacific Antimalarial Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Antimalarial Medication Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. Latin America Antimalarial Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Antimalarial Medication Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. Middle East and Africa Antimalarial Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
自己管理薬の世界市場（～2026年） Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient. By distribution channel, the hospital pharmacies segment is expected to repr…- 薬物療法管理の世界市場（～2026年） Medication therapy management, generally called medicine use review in the United kingdom, is a service provided typically by pharmacists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. This includes providing educ…
- ペット用医薬品の世界市場（～2026年） Market Analysis and Insights: Global Pet Medication Market The global Pet Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pet Medication Scope and Market Size Pet Medication market is segmented by Type, and …
- インフルエンザ治療薬の世界市場（～2026年） Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disor…
- 遠隔薬局の世界市場（～2026年） Telepharmacy is considered to be a way of delivering pharmaceutical products and care by the means of telecommunication to different patients. This way patients can receive their medicines and other pharmaceutical care items in the comfort of where they can get the services easy. Some of the service…